Sabine Maamari
COO Avocet Bio
Seminars
Tuesday 27th January 2026
RNA Editing in the Lung: Programmable Nucleases & Next-Gen Inhaled Delivery for Respiratory Disease
2:30 pm
- Exploring next-generation RNA modalities from programmable nucleases to emerging enzyme systems for therapeutic use in the lung
- Case study: leveraging a Cas13 platform to counter respiratory viral infections
- Designing inhalable delivery vehicles for safe, efficient deposition throughout the airways
